Perspective
Our work in Perspective
-
COVID-19 Is on the Run — Expect the Pandemic to Be Under Control by Memorial Day
Rising immunity from vaccines and prior exposure means we should have COVID-19 cornered by Memorial Day. That doesn’t mean the virus will be out of our lives. But its impact should be reduced to something approaching a normal flu season in terms of deaths and hospitalizations.
Categorized in -
Medicare Payment for Physician-Administered (Part B) Drugs: The Interim Final Rule and a Better Way Forward
A look at how policymakers can reform an interim-final rule to use Medicare’s demonstration authority under the Center for Medicare and Medicaid Innovation (CMMI) to make large reductions in the amounts it pays physicians for high-cost medicines they administer under Part B.
-
The Best Vaccination Strategy is Simple: Focus on Americans 65 and Older
The most ethically justified path forward for COVID-19 vaccine distribution is to focus on individuals 65 and older. This group accounts for 80% of COVID-19 deaths despite making up only 16% of the population.
Categorized in -
Understanding the No Surprises Act
A look at the No Surprise Act, a new federal law that ends surprise out-of-network billing. The law was passed late last year as part of the omnibus bill.
-
Reducing Administrative Waste in the US Health Care System
Eliminating administrative expense has the benefit of lowering health care costs without affecting spending on patient care.
Categorized in -
Those Previously Infected with COVID-19 Should Delay Getting a Vaccination
Policymakers should ask the millions of people who have already survived the coronavirus infection to step to the back of the line for vaccines, argue Neeraj Sood and colleagues in CalMatters.
Categorized in -
Travel Bans Should Be Based on Evidence, Not Politics or Fear
Scientific evidence suggests that extending travel bans will not make Americans safer, and instead result in adverse consequences for millions of family members who have been separated for over 10 months.
Categorized in -
The U.S. is Overlooking this Powerful Tool to Loosen the COVID-19 Vaccine Logjam
Local, independent pharmacies are being overlooked, and that’s a mistake.
Categorized in -
Legalizing Marijuana, once a Pipe Dream on Capitol Hill, Takes an Important Step Forward
Rosalie Liccardo Pacula writes about strengths and weakness in the MORE Act along with additional policy ideas that could strengthen regulation and better protect consumers.
Categorized in -
Will the Rebate Rule need Extra Innings?
The publication of the final rebate rule is an important milestone in this administration’s drug pricing journey. However, many challenges remain.
Categorized in